Clinical Trial Update: Study With [225Ac]Ac-FL-020 in mCRPC Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for [225Ac]Ac-FL-020 in metastatic castration-resistant prostate cancer. The study (NCT06492122) is currently recruiting under s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• [225Ac]Ac-FL-020

Snippet

Sponsor: Full-Life Technologies GmbH | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1 | Status: RECRUITING